Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020
Addiction · 2026
DOI: 10.1111/add.70489 ↗At a glance
Beobachtungsstudie in Addiction, 2026. Written by Ruyu Yan and 13 co-authors. Institution: Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada. Major MEDLINE topics: Opioid-Related Disorders, Opiate Substitution Treatment, Analgesics, Opioid, Drug Tapering. 53 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIDA NIH HHS, Health Canada Substance Use and Addictions Program, National Institutes of Health/National Institute on Drug Abuse.
Topics: Sucht und Abhängigkeit
Abstract (original language)
Background and aims Opioid use disorder (OUD) treatment guidelines worldwide recommend opioid agonist treatment (OAT) as a long‐term, potentially indefinite treatment for managing OUD. However, many individuals express a strong interest in eventually tapering fully off treatment. Current clinical practice guidelines offer relatively limited guidance or evidence on the appropriate timing to initiate a taper. We aimed to determine the safety and comparative effectiveness of different times from completion of OAT induction at which tapering could be considered to maximize the likelihood of taper completion and minimize the risk of mortality.
Design
Population‐based retrospective observational study and target trial emulation based on nine linked administrative health databases.
Setting
British Columbia, Canada, from 1 January 2010 to 17 March 2020.
Participants
Individuals (identified via linkage of nine provincial health administrative databases) completing OAT induction with methadone or buprenorphine/naloxone who were ≥18 years of age with no known pregnancy, no history of cancer or palliative care and not currently incarcerated. We executed both incident‐user (no OAT experiences) and prevalent‐new‐user (no OAT within the past month) analyses. Intervention and comparator The time between completed OAT induction and taper initiation:
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.
- Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
- Medical Research Council (MRC) Biostatistics Unit, University of Cambridge, Cambridge, UK.
- British Columbia Centre on Substance Use (BCCSU), Vancouver, British Columbia, Canada.
- Department of Medicine, UBC Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Epidemiology and Department of Statistics, The University of California, Los Angeles, Los Angeles, California, USA.
ORCID profiles: Ruyu Yan, Megan Kurz, Paxton Bach
Funding
- NIDA NIH HHS
- Health Canada Substance Use and Addictions Program
- National Institutes of Health/National Institute on Drug Abuse
Cite
APA
Yan, R., Min, J. E., Kurz, M., Seaman, S. R., Bach, P., Greenland, S., Gustafson, P., Karim, M. E., McCandless, L., Platt, R. W., Siebert, U., Socías, M. E., Xie, H., & Nosyk, B. (2026). Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020. Addiction. https://doi.org/10.1111/add.70489
Vancouver
Yan R, Min JE, Kurz M, Seaman SR, Bach P, Greenland S, et al. Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020. Addiction. 2026. doi:10.1111/add.70489
BibTeX
@article{Yan2026,
author = {Yan, Ruyu and Min, Jeong Eun and Kurz, Megan and Seaman, Shaun R and Bach, Paxton and Greenland, Sander and Gustafson, Paul and Karim, Mohammad Ehsanul and McCandless, Lawrence and Platt, Robert William and Siebert, Uwe and Socías, María Eugenia and Xie, Hui and Nosyk, Bohdan},
title = {Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70489}
}
EUVIMED